Four leading medical societies released a coordinated framework to identify and manage cardiovascular risk in girls and women from puberty through menopause. The Female Life Stage
guidelines aim to reduce fragmented care by connecting obstetric, gynecologic, and cardiovascular specialties.
Cardiovascular disease kills more than 400,000 women in the U.S.—a figure that is the leading cause of death among U.S. women. Despite this, only 4 in 10 women are aware that cardiovascular disease is the biggest threat to their health. To address this disparity, a collective clinical playbook has been created by the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine.
The Female Life Stage Framework
The new guidelines shift away from treating heart health as a late-life concern, instead anchoring risk assessment to hormonal transitions unique to females. This approach recognizes that cardiovascular health is deeply linked to hormonal and emotional well-being. The framework was published as three papers in the American Heart Association journal Circulation, including a presidential advisory, a scientific statement for clinical guidance, and a science advisory regarding a proposed centers network.
This joint Scientific Statement on behalf of @American_Heart, @AmerAcadPeds, @acog and the Society for Maternal-Fetal presents stage-specific clinical guidance across the interconnected domains of hormonal health, psychosocial health, and cardiovascular (CV) health across the… pic.twitter.com/CuxrjpYYha
- Stage 1 (Perimenarche): Transition around the first menstrual period, typically ages 8 to 15.
- Stage 2 (Ovarian Cycling): Established regular cycles and the period when pregnancy typically occurs, ages 15 to 44.
- Stage 3 (Perimenopause): Transition characterized by variable cycle lengths, skipped cycles, and hormone changes, typically ages 45 to 51.
- Stage 4 (Postmenopause): The period starting 12 months after the final menstrual period, typically age 51 and older.
Pregnancy is categorized as a biological stress test
that can occur across multiple stages. According to the framework, this period can unmask previously unrecognized cardiovascular risks. Routine depression and anxiety screening, starting at 12 and 13, respectively, are also noted as part of the framework’s guidance.
Early biological markers are also highlighted. A higher risk of heart disease in later life is associated with experiencing a first period before age 10. Furthermore, irregular or heavy menstrual bleeding can act as early indicators of cardiovascular risk, including polyendocrine metabolic ovarian syndrome (PMOS), which was previously called polycystic ovary syndrome (PCOS). Dr. Sadiya Khan, chair of the collaborative writing group and Magerstadt Professor of Cardiovascular Epidemiology at Northwestern University Feinberg School of Medicine, noted that conditions often viewed primarily through a reproductive-health lens may serve as early indicators of future risk.

Preventing the 2050 Blood Pressure Surge
The urgency for this framework is driven by a 2026 American Heart Association forecast. If current trends persist, the percentage of U.S. women ages 20 and older with high blood pressure is projected to rise from 49% in 2020 to 59% by 2050.
Current care gaps exacerbate these risks. To address this, the new guidance suggests identifying cardiovascular risk earlier and delivering more personalized care to girls and women throughout life.
From the first period through the years after menopause, a woman has four stages of her life. The American Heart Association, American Academy of Pediatrics, American College of Obstetricians & Gynecologists and Society for Maternal-Fetal Medicine developed a framework to… pic.twitter.com/u7t4dbRw4f
Perimenopause as a Window of Opportunity
Clinicians are encouraged to view perimenopause not just as a reproductive transition, but as a cardiovascular inflection point. Dr. Jayne Morgan, a cardiologist and Bayer® Aspirin Partner, notes that symptoms like night sweats and hot flashes are not just gynecologic indicators, but are reflections of advancing heart risk. During the menopause transition, changes in estrogen levels are associated with changes in body composition, blood sugar, blood pressure, and cholesterol.
Dr. Morgan emphasizes the importance of knowing key metrics, stating that blood pressure should be less than 120/80.

These projections underscore the urgency of making cardiovascular health a priority at every stage of a woman’s life. This new approach gives clinicians across specialties shared guidance to recognize risk earlier, personalize prevention, and act before a heart attack, stroke or heart failure event.
Dr. Sadiya Khan
Research presented at The Menopause Society’s 2026 annual meeting analyzed postmenopausal women. The study followed participants for an average of 21.4 years, during which 1,570 cardiovascular events occurred. The findings indicated that women who reached menopause before age 40 had a 30% higher risk of coronary heart disease and a 19% higher risk of overall cardiovascular disease compared to those who reached menopause at 45 or later. This risk was not linked to heart failure or stroke.
Dr. Stephanie Faubion, medical director of The Menopause Society, stated that this study suggests insulin resistance may be one of the biological pathways involved, as women with premature menopause had 9.9% higher scores on a standard insulin resistance measure and 9.3% higher insulin levels. However, the findings show an association rather than proof. Premature menopause occurring before 40 is already identified in the 2019 ACC/AHA prevention guideline as a factor that can increase estimated heart risk.
For too long, women's health has been approached in separate silos. A new life-stage approach helps connect hormonal, heart and overall health, giving women more personalized care at every age.The American Heart Association, American Academy of Pediatrics, American College of… pic.twitter.com/ZKW13DFAeP
Centers of Excellence and Integrated Care
To end the fragmentation of care
between ob-gyns and cardiologists, the four societies are calling for a national infrastructure of Comprehensive Centers of Excellence for Women’s Cardiovascular Care. These centers would be built on four pillars: interdisciplinary clinical care, research, community engagement, and professional education. The goal is to reduce fragmentation, increase the representation of women in clinical research, and encourage health systems to promote greater awareness of female risk.
The goal is to create a shared playbook
where menstrual cycle patterns—specifically heavy or irregular bleeding—are recognized as female-specific vital signs and early markers of heart risk. Dr. Amanda Marma Perak, vice-chair of the collaborative writing group and a pediatric cardiologist at Lurie Children’s Hospital in Chicago, emphasizes that heart health begins long before adulthood
and that foundational early years matter.

Women are encouraged to be proactive about their health. Those who experienced natural menopause before age 40, survivors of cancer treatment that ended ovarian function, or those whose ovaries were removed at a young age should consult a qualified healthcare professional to discuss blood sugar, cholesterol, and blood pressure checks.